{"id":3995,"date":"2023-02-16T18:08:02","date_gmt":"2023-02-16T18:08:02","guid":{"rendered":"https:\/\/mirm-pitt.net\/technologies\/?post_type=avada_portfolio&p=3995"},"modified":"2023-02-16T18:08:02","modified_gmt":"2023-02-16T18:08:02","slug":"ecm-hydrogel-for-treating-esophageal-inflammation","status":"publish","type":"avada_portfolio","link":"https:\/\/mirm-pitt.net\/technologies\/patents\/ecm-hydrogel-for-treating-esophageal-inflammation\/","title":{"rendered":"ECM hydrogel for treating esophageal inflammation"},"content":{"rendered":"

ECM hydrogel for treating esophageal inflammation<\/h1>\n
\n
\n
\n

<\/h2>\n<\/section>\n<\/div>\n<\/div>\n
\n
\n
\n

<\/h2>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div><\/div><\/div>

Inventors: <\/strong>Stephen Francis Badylak: Juan Diego Naranjo <\/span>Gutierrez: Lindsey<\/span> Tamiko Saldin<\/span>
\n<\/strong><\/p>\n

Patent Number:<\/strong> 11,213,545<\/p>\n

\n
\n
\n

Abstract<\/h3>\n
\n
\n
Methods are disclosed for inhibiting esophageal inflammation in a subject, that include administering to the esophagus of the subject with esophageal inflammation a therapeutically effective amount of an extracellular matrix (ECM) hydrogel. Methods are also disclosed for reducing esophageal stricture. Compositions are disclosed that include an esophageal extracellular matrix (ECM) hydrogel.<\/div>\n<\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div>
<\/div>
<\/div>